# ResMed Inc. (RMD): MoatMap facts

As of 12 Nov 2026. Research data, not investment advice.

As of 12 Nov 2026, the MoatMap Score for ResMed Inc. (RMD) is 88/100, ranked against 25,000+ stocks in 38 markets (Quality 85, Value 44, Momentum 61, each scored against its sector).

- MoatMap Score: 88/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 85, Value 44, Momentum 61: each a 0-100 percentile within Healthcare.
- Position: #3,181 overall, #358 in Healthcare.
- Listing: United States, NYQ; Healthcare / Medical Instruments & Supplies.
- Last close: 238.53 USD on 11 Nov 2026.
- Insider filings, last 180 days: directors sold USD 7.5M.
- Buybacks, last 180 days: the company bought back USD 1.4B on 2 days.

Source: https://moatmap.ai/stock/RMD
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker